Interval between hepatocellular carcinoma treatment and interferon-free direct-acting antiviral agents against hepatitis C is necessary to suppress tumor recurrence

Interferon (IFN) has been identified to suppress carcinogenesis when used for treating hepatitis C virus (HCV) infections. Treatment with IFN-free direct-acting antiviral agents (DAAs) is an acceptable alternative, even in elderly patients or patients who have been treated for hepatocellular carcino...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Clin Oncol
Main Authors: Iida, Hiroya, Osaki, Rie, Fujimoto, Takehide, Maehira, Hiromitsu, Mori, Haruki, Kitamura, Naomi, Andoh, Akira, Tani, Masaji
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535632/
https://ncbi.nlm.nih.gov/pubmed/31289685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1847
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares